Open AccessEnhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer
Author(s) -
Tomokatsu Kato,
Yoichi Matsuo,
Goro Ueda,
Hiromichi Murase,
Yoshinaga Aoyama,
Kan Omi,
Yuichi Hayashi,
Hiroyuki Imafuji,
Kenta Saito,
Mamoru Morimoto,
Ryo Ogawa,
Hiroki Takahashi,
Shuji Takiguchi
Publication year - 2022
Publication title -
oncology reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8279
Subject(s) - cxcr4 antagonist , cxcr4 , oncogene , biology , cancer research , chemokine receptor , chemokine , pancreatic cancer , cell culture , cell , cell growth , cell cycle , microbiology and biotechnology , receptor , cancer , biochemistry , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom